Skip to main content
Lunai Bioworks Inc. logo

Lunai Bioworks Inc. — Investor Relations & Filings

Ticker · RENB ISIN · US29350E1047 US Professional, scientific and technical activities
Open in API
Filings indexed 580 across all filing types
Latest filing 2014-05-14 Interim / Quarterly Rep…
Country US United States of America
Listing US RENB

About Lunai Bioworks Inc.

https://www.lunaibio.com

Lunai Bioworks Inc. is a pre-clinical stage biotechnology company that utilizes artificial intelligence for drug discovery and biodefense. The company focuses on pioneering safe and responsible generative biology to develop new therapies. By harnessing phenomics and AI, it aims to decode disease signals and translate them into treatments. Its proprietary Transformer Platform is designed to accelerate drug discovery processes. Lunai Bioworks develops medicines, diagnostics, and biodefense products, with a pipeline that includes programs for neurodegenerative conditions like Alzheimer's disease.

Recent filings

Filing Released Lang Actions
QUARTERLY REPORT
Interim / Quarterly Report Q1 2014
2014-05-14 English
Regulatory Filings 2014
Regulatory Filings
2014-04-17 English
AMENDED CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is an amended Form 8-K (8-K/A) filed with the SEC, which is a Current Report used to disclose major events that shareholders should know about. The text includes detailed disclosures about a share exchange agreement, changes in control, changes in management and board of directors, completion of acquisition, and other corporate events. It references multiple Form 8-K items such as Item 1.01 (Entry into a Material Definitive Agreement), Item 2.01 (Completion of Acquisition or Disposition of Assets), Item 3.02 (Unregistered Sales of Equity Securities), Item 4.01 (Changes in Certifying Accountant), Item 5.01 (Changes in Control), and Item 5.02 (Departure and Appointment of Directors and Officers). The document is not a full annual or quarterly report, nor is it a transcript, presentation, or earnings release. It is a regulatory filing reporting significant corporate events and changes. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length (15,000 characters) and content confirm it is a substantive filing, not a brief announcement or certification only.
2014-03-31 English
REGISTRATION STATEMENT
Capital/Financing Update Classification · 100% confidence The document is a Form S-1/A, which is a registration statement filed with the SEC under the Securities Act of 1933. It is used for registering securities for an initial public offering (IPO) or resale of shares. The text includes details about the offering, the company, the registration fee, and the prospectus summary. This type of filing is related to capital raising activities and financing, not an annual report, earnings release, or other types of filings. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering information, confirming it is not merely an announcement but the actual registration statement.
2014-03-31 English
Regulatory Filings 2014
Regulatory Filings
2014-03-17 English
OWNERSHIP DOCUMENT
Director's Dealing
2014-02-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.